在孕期糖尿病中,Faecalibacterium prasnitzii的优势
Hanieh Safarzadeh1, Amir Aliramezani2, Arian Rahimi3
1Department of Microbiology and Virology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.
Future microbiology
|June 27, 2025
概括
孕期糖尿病 (GDM) 影响孕妇,并可能导致未来的健康问题. 本综述探讨了GDM的原因和影响,强调了Faecalibacterium prasnitzii作为肠道健康的潜在治疗点.
科学领域:
- 微生物学 微生物学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 代谢障碍,包括妊娠期糖尿病 (GDM),在全球范围内正在增加.
- 怀孕期间的GDM对母亲和孩子都有风险,包括肥胖和2型糖尿病等长期并发症.
- 肠道微生物群失生症与各种健康状况有关.
研究的目的:
- 审查孕妇GDM的原因和影响.
- 探索益生菌,特别是Faecalibacterium prasnitzii在管理GDM中的作用.
- 突出F. prasnitzii作为一个生物标志物和潜在的治疗剂.
主要方法:
- 文献综述侧重于GDM,肠道微生物群和益生菌.
- 对研究Faecalibacterium prasnitzii及其代谢产物的研究进行分析.
- 对肠道健康和GDM之间的联系进行当前研究的综合.
主要成果:
- GDM与胎盘胰岛素耐药性和对母亲和后代的不良结果有关.
- *Faecalibacterium prasnitzii* 是一种关键的酸盐生产肠道细菌.
- 益生菌可能有助于恢复肠道微生物群平衡,调节免疫功能.
结论:
- *Faecalibacterium prasnitzii*作为健康和疾病的生物标志物显示出希望.
- "F. prasnitzii"的抗炎性质表明,它对GDM有潜在的治疗应用.
- 对"F. prasnitzii"的进一步研究可能会导致新的GDM管理策略.
相关概念视频
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Dipeptidyl Peptidase 4 Inhibitors
270
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
270
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
272
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
272
Oral Hypoglycemic Agents: Biguanides and Glitazones
309
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
309
Glucose Transporters
24.3K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
24.3K


